Group One Trading, L.P. Tempest Therapeutics, Inc. Call Options Transaction History
Group One Trading, L.P.
- $2.54 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TPST
# of Institutions
39Shares Held
6.35MCall Options Held
34.9KPut Options Held
148K-
Versant Venture Management, LLC San Francisco, CA3.51MShares$2.95 Million4.35% of portfolio
-
Black Rock Inc. New York, NY550KShares$462,2020.0% of portfolio
-
Jane Street Group, LLC New York, NY493KShares$414,1980.0% of portfolio
-
Geode Capital Management, LLC Boston, MA354KShares$297,5910.0% of portfolio
-
Ubs Group Ag196KShares$164,3670.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $8.75M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...